Free Trial

Stevanato Group (STVN) Competitors

€21.38
-0.35 (-1.61%)
(As of 07/19/2024 08:56 PM ET)

STVN vs. NYXH, SYK, BSX, BDX, MMM, DXCM, RMD, WST, BAX, and PODD

Should you be buying Stevanato Group stock or one of its competitors? The main competitors of Stevanato Group include Nyxoah (NYXH), Stryker (SYK), Boston Scientific (BSX), Becton, Dickinson and Company (BDX), 3M (MMM), DexCom (DXCM), ResMed (RMD), West Pharmaceutical Services (WST), Baxter International (BAX), and Insulet (PODD). These companies are all part of the "surgical & medical instruments" industry.

Stevanato Group vs.

Nyxoah (NASDAQ:NYXH) and Stevanato Group (NYSE:STVN) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, community ranking, media sentiment, valuation, profitability and analyst recommendations.

Nyxoah has a beta of 1.43, suggesting that its share price is 43% more volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500.

Stevanato Group has higher revenue and earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nyxoah$5.13M44.26-$46.77M-$1.64-5.55
Stevanato Group$1.17BN/A$157.62M$0.5538.87

Stevanato Group has a net margin of 12.57% compared to Stevanato Group's net margin of -843.49%. Nyxoah's return on equity of 12.61% beat Stevanato Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Nyxoah-843.49% -42.14% -33.55%
Stevanato Group 12.57%12.61%7.25%

Nyxoah currently has a consensus target price of $17.80, suggesting a potential upside of 95.60%. Given Stevanato Group's stronger consensus rating and higher possible upside, equities analysts clearly believe Nyxoah is more favorable than Stevanato Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nyxoah
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
Stevanato Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

Nyxoah received 5 more outperform votes than Stevanato Group when rated by MarketBeat users. Likewise, 67.39% of users gave Nyxoah an outperform vote while only 61.90% of users gave Stevanato Group an outperform vote.

CompanyUnderperformOutperform
NyxoahOutperform Votes
31
67.39%
Underperform Votes
15
32.61%
Stevanato GroupOutperform Votes
26
61.90%
Underperform Votes
16
38.10%

In the previous week, Stevanato Group had 2 more articles in the media than Nyxoah. MarketBeat recorded 3 mentions for Stevanato Group and 1 mentions for Nyxoah. Stevanato Group's average media sentiment score of 0.00 beat Nyxoah's score of -0.25 indicating that Nyxoah is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nyxoah
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Stevanato Group
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Stevanato Group beats Nyxoah on 8 of the 14 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STVN vs. The Competition

MetricStevanato GroupSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market CapN/A$3.85B$5.30B$18.45B
Dividend YieldN/A1.72%2.76%3.50%
P/E Ratio38.8715.30124.9125.11
Price / SalesN/A65.942,172.5815.22
Price / Cash25.0449.1036.5219.88
Price / Book5.154.274.895.05
Net Income$157.62M$3.48M$112.28M$974.25M
7 Day Performance-1.52%-0.60%-0.66%0.04%
1 Month Performance20.18%2.15%7.27%4.53%
1 Year Performance-34.98%9.70%6.33%7.30%

Stevanato Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NYXH
Nyxoah
0.8864 of 5 stars
0.89 / 5 stars
$9.10
-0.1%
$17.80
+95.6%
+12.2%$0.00$4.70M-5.55110Gap Up
SYK
Stryker
4.7403 of 5 stars
4.74 / 5 stars
$340.95
+2.9%
$372.05
+9.1%
+15.2%$126.18B$20.50B38.9252,000Positive News
High Trading Volume
BSX
Boston Scientific
4.6662 of 5 stars
4.67 / 5 stars
$77.58
+2.7%
$82.29
+6.1%
+45.1%$113.81B$14.24B65.1948,000Upcoming Earnings
Analyst Forecast
Options Volume
News Coverage
BDX
Becton, Dickinson and Company
4.8092 of 5 stars
4.81 / 5 stars
$230.74
-0.4%
$280.14
+21.4%
-12.4%$66.69B$19.37B50.8273,000News Coverage
MMM
3M
4.5478 of 5 stars
4.55 / 5 stars
$103.90
-0.1%
$112.17
+8.0%
-0.4%$57.56B$32.68B-8.1785,000Upcoming Earnings
News Coverage
DXCM
DexCom
4.8816 of 5 stars
4.88 / 5 stars
$111.66
+0.9%
$139.33
+24.8%
-14.5%$44.40B$3.62B72.049,600Upcoming Earnings
News Coverage
RMD
ResMed
4.539 of 5 stars
4.54 / 5 stars
$203.26
-0.3%
$202.80
-0.2%
-7.4%$29.95B$4.22B31.2210,140News Coverage
Positive News
WST
West Pharmaceutical Services
4.9804 of 5 stars
4.98 / 5 stars
$317.90
+0.5%
$442.75
+39.3%
-16.1%$23.04B$2.95B41.9410,600Upcoming Earnings
News Coverage
Positive News
BAX
Baxter International
4.7675 of 5 stars
4.77 / 5 stars
$35.34
-1.0%
$42.67
+20.7%
-28.3%$18.01B$14.81B6.8060,000Dividend Announcement
Options Volume
News Coverage
PODD
Insulet
4.8305 of 5 stars
4.83 / 5 stars
$195.03
+0.0%
$239.18
+22.6%
-30.1%$13.65B$1.70B59.103,000Analyst Revision
News Coverage
Positive News

Related Companies and Tools

This page (NYSE:STVN) was last updated on 7/21/2024 by MarketBeat.com Staff

From Our Partners